Tumor margin histology predicts tumor aggressiveness in papillary thyroid carcinoma: A study of 514 consecutive patients

Journal of Korean Medical Science

Volumn 26, Issue 3, 2011, Pages 346-351

  Kim, Kuk Jin ^a   Hong, Soon Won ^a   Lee, Yong Sang ^a   Kim, Bup Woo ^a   Lee, Seung Chul ^a   Chang, Hang Seok ^a   Park, Cheong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Aggressiveness; Carcinoma; Histology; Margin; Papillary; Thyroid

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; THYROID TUMOR;

ADULT; CELL PROLIFERATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; THYROID NEOPLASMS;

EID: 79953735267     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.3.346     Document Type: Article

References (23)

1. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, Park EC, Lee JS. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25: 1113-21.
2. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year followup report of the impact of therapy in 576 patients. Am J Med 1981; 70: 511-8.
3. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-24.
4. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009.
5. Lin YK, Sheng JM, Zhao WH, Wang WB, Yu XF, Teng LS, Ma ZM. Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases. Zhonghua Wai Ke Za Zhi 2009; 47: 450-3.
6. Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, Shong YK. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) 2004; 61: 145-8.
7. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998; 8: 197-202.
8. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 458-63.
9. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2009; 71: 581-6.
10. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001; 25: 632-7.
11. Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 2008; 33: 1-5.
12. Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 1988; 12: 22-7.
13. Moreno Egea A, Rodriguez Gonzalez JM, Sola Perez J, Soria Cogollos T, Parrilla Paricio P. Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol 1993; 19: 517-21.
14. Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer 1998; 82: 740-53.
15. Ito Y, Hirokawa M, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A. Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology 2008; 40: 617-22.
16. Caron NR, Clark OH. Well differentiated thyroid cancer. Scand J Surg 2004; 93: 261-71.
17. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306.
18. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1: 1303-6.
19. Rajaganeshan R, Prasad R, Guillou PJ, Chalmers CR, Scott N, Sarkar R, Poston G, Jayne DG. The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer 2007; 96: 1112-7.
20. Zlobec I, Terracciano LM, Lugli A. Local recurrence in mismatch repairproficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes. Clin Cancer Res 2008; 14: 3792-7.
21. González-Vela MC, Garijo MF, Fernández FA, Buelta L, Val-Bernal JF. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors. Pathol Res Pract 1999; 195: 611-8.
22. Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil S, Van Zee KJ. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 2007; 14: 2961-70.
23. Mai KT, Perkins DG, Yazdi HM, Commons AS, Thomas J, Meban S. Infiltrating papillary thyroid carcinoma: review of 134 cases of papillary carcinoma. Arch Pathol Lab Med 1998; 122: 166-71.